Jelena L Holovati
Overview
Explore the profile of Jelena L Holovati including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
212
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Parmar G, Seftel M, Ganz K, Blake J, Holovati J, Allan D
Curr Oncol
. 2024 May;
31(5):2542-2551.
PMID: 38785471
HLA-matched allogeneic hematopoietic cell transplantation (HCT) is a curative therapy for many patients. Unrelated HLA-matched donors are the most frequently used donor for HCT. When more than one donor transplant...
2.
Howell A, Letcher B, Murphy K, Elmoazzen H, Petraszko T, Acker J, et al.
Transfusion
. 2022 Jul;
62(9):1818-1828.
PMID: 35851676
Background: Collection of HPC by apheresis (HPC-A) can sometimes result in higher collection volumes, increasing the dimethyl sulfoxide (DMSO) volume infused into patients and the space requirements in liquid nitrogen...
3.
Trepanier P, Fournier D, Simard C, Fontaine M, Stroncek D, Takanashi M, et al.
Transfusion
. 2022 Jun;
62(8):1595-1601.
PMID: 35770742
Background: The IL-3-pSTAT5 assay, a new, rapid, and standardized flow-cytometry-based assay may compensate for several limitations of the colony-forming unit (CFU) assay typically used for stem cell potency assessments of...
4.
Da Silveira Cavalcante L, Acker J, Holovati J
Biopreserv Biobank
. 2018 Jul;
16(4):304-311.
PMID: 30010418
Background: Ex vivo cold storage of red blood cells (RBCs) for transfusion has long been associated with hypothermic storage lesions. It has been proposed that liposomes can be used to...
5.
Almizraq R, Holovati J, Acker J
Transfus Med Hemother
. 2018 Jun;
45(3):185-193.
PMID: 29928174
Background: Extracellular vesicles (EVs) in blood products are potential effectors of inflammation and coagulation after transfusion. The aim of this study was to assess the impact of different blood manufacturing...
6.
Kipkeu B, Shyian M, Da Silveira Cavalcante L, Duong T, Yeung R, Binnington B, et al.
Transfusion
. 2018 May;
58(8):2027-2035.
PMID: 29744883
Background: Monocyte monolayer assay (MMA) is a compatibility testing method for evaluating the clinical significance of red blood cell (RBC) alloantibodies. Time-consuming monocyte isolation procedures and requirement for fresh monocytes...
7.
Almizraq R, Seghatchian J, Holovati J, Acker J
Transfus Apher Sci
. 2017 Apr;
56(2):254-260.
PMID: 28363591
Extracellular vesicles (EVs), including microvesicles and exosomes, are small phospholipid vesicles (≤1μm in diameter) that are present in blood products, accumulate during storage, and have a potential transfusion-related immunomodulatory role....
8.
Da Silveira Cavalcante L, Branch D, Duong T, Yeung R, Acker J, Holovati J
J Liposome Res
. 2017 Mar;
28(3):173-181.
PMID: 28276279
Our in vivo studies on a rat model established safety of transfusing liposome-treated red blood cells (RBCs) but identified the potential for immune modulation as related to transfusion efficacy of...
9.
Da Silveira Cavalcante L, Feng Q, Chin-Yee I, Acker J, Holovati J
J Liposome Res
. 2016 Apr;
27(1):56-63.
PMID: 27055898
Context: Liposomes have been shown to improve human red blood cell (RBC) in vitro quality by minimizing membrane damage occurring during 42-d hypothermic storage. Small animal models are necessary to...
10.
Perepelkin N, Hayward K, Mokoena T, Bentley M, Ross-Rodriguez L, Marquez-Curtis L, et al.
Cell Tissue Bank
. 2015 Sep;
17(1):39-50.
PMID: 26361949
Amniotic membrane (AM) transplantation is increasingly used in ophthalmological and dermatological surgeries to promote re-epithelialization and wound healing. Biologically active cells in the epithelial and stromal layers deliver growth factors...